Blog

At Fennemore, growth has always been more about the people than geography. We look for firms and attorneys who share our people-first mindset, forward-thinking approach, and unwavering client focus—leaders who build culture deliberately and make long-term decisions about the businesses they create. Growth should reinforce identity, not dilute it.…

As of March 1, 2026, certain residential real estate transactions trigger a new federal reporting obligation under regulations issued by the Financial Crimes Enforcement Network, a bureau of the U.S. Treasury Department. The Residential Real Estate Reporting Rule, codified at 31 CFR § 1031.320, requires designated professionals involved in real es…

As Black History Month concludes, we’ve reflected on the many ways our team chose to engage, serve, and learn throughout February. While the month offers an opportunity to recognize the enduring contributions of Black Americans to our country’s history and legal system, it also invites something deeper — sustained learning, meaningful service…

Fennemore attorneys across the firm have earned recognition on the 2026 Super Lawyers^® and Rising Stars^® lists, reflecting their individual leadership, professional achievement, and standing among peers.

As Read More

When Ilia Malinin steps onto the ice in Milano–Cortina, he is not only competing for medals. He is also competing in the modern attention economy, where a single performance can drive millions of views, followers, and (sometimes) sponsorship inquiries. That visibility is a commercial opportunity, but it is also a legal and contractual risk, becau…

Biotech startups, like all emerging companies, face a gauntlet of operational and financial challenges inherent to the startup ecosystem. Yet, their journey is uniquely complicated by industry-specific hurdles that set them apart from ventures in other sectors. At the heart of a biotech company lies its intellectual property (IP)—a cornerstone th…